Kabra Drugs has informed that, the Meeting of Board of Directors of the Company was held on Tuesday, 29th of June, 2021 at registered office at 12:30 pm and concluded at 6:30 pm. The outcome of the Board meeting, is as under: Approval of the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2021. The Board considered and approved the unaudited results for the 4th quarter and financial year ended 31st March, 2021 pursuant to regulation 33 of the listing regulations. A copy of same is enclosed.
The above information is a part of company’s filings submitted to BSE.
